

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of gene silencing by RNA (GO:0060966) | 6.15889639 |
| 2 | regulation of posttranscriptional gene silencing (GO:0060147) | 6.15889639 |
| 3 | regulation of gene silencing by miRNA (GO:0060964) | 6.15889639 |
| 4 | establishment of integrated proviral latency (GO:0075713) | 5.76560225 |
| 5 | pre-miRNA processing (GO:0031054) | 5.23816700 |
| 6 | protein complex localization (GO:0031503) | 4.86963839 |
| 7 | establishment of viral latency (GO:0019043) | 4.65207650 |
| 8 | COPI coating of Golgi vesicle (GO:0048205) | 4.58200185 |
| 9 | Golgi transport vesicle coating (GO:0048200) | 4.58200185 |
| 10 | heterochromatin organization (GO:0070828) | 4.52684236 |
| 11 | paraxial mesoderm development (GO:0048339) | 4.30099275 |
| 12 | L-serine metabolic process (GO:0006563) | 4.23102142 |
| 13 | histone arginine methylation (GO:0034969) | 4.16916605 |
| 14 | regulation of early endosome to late endosome transport (GO:2000641) | 4.13795460 |
| 15 | protein localization to kinetochore (GO:0034501) | 4.07172359 |
| 16 | nuclear pore complex assembly (GO:0051292) | 4.06776528 |
| 17 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.00406534 |
| 18 | cellular protein complex localization (GO:0034629) | 3.99180041 |
| 19 | DNA unwinding involved in DNA replication (GO:0006268) | 3.92409025 |
| 20 | natural killer cell mediated immunity (GO:0002228) | 3.89622121 |
| 21 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.89622121 |
| 22 | regulation of histone H3-K9 methylation (GO:0051570) | 3.85554986 |
| 23 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.83595173 |
| 24 | regulation of helicase activity (GO:0051095) | 3.83367236 |
| 25 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.77649836 |
| 26 | chromatin remodeling at centromere (GO:0031055) | 3.76487167 |
| 27 | protein localization to chromosome, centromeric region (GO:0071459) | 3.72467100 |
| 28 | IMP biosynthetic process (GO:0006188) | 3.72150500 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.69524400 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.69524400 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 3.69524400 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 3.69524400 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 3.69524400 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.69524400 |
| 35 | nuclear pore organization (GO:0006999) | 3.68947089 |
| 36 | DNA damage response, detection of DNA damage (GO:0042769) | 3.67770446 |
| 37 | CENP-A containing nucleosome assembly (GO:0034080) | 3.67178934 |
| 38 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.65668153 |
| 39 | DNA replication-independent nucleosome organization (GO:0034724) | 3.65668153 |
| 40 | localization within membrane (GO:0051668) | 3.65190206 |
| 41 | formation of translation preinitiation complex (GO:0001731) | 3.62215293 |
| 42 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.59641478 |
| 43 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.58051549 |
| 44 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55036048 |
| 45 | negative regulation of RNA splicing (GO:0033119) | 3.52142830 |
| 46 | regulation of cell fate specification (GO:0042659) | 3.51742311 |
| 47 | negative regulation of histone methylation (GO:0031061) | 3.47806733 |
| 48 | neutrophil activation involved in immune response (GO:0002283) | 3.45767883 |
| 49 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.45115868 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.45115868 |
| 51 | IMP metabolic process (GO:0046040) | 3.43278826 |
| 52 | ATP-dependent chromatin remodeling (GO:0043044) | 3.42566648 |
| 53 | protein localization to endosome (GO:0036010) | 3.40381751 |
| 54 | peptidyl-arginine methylation (GO:0018216) | 3.35866862 |
| 55 | peptidyl-arginine N-methylation (GO:0035246) | 3.35866862 |
| 56 | negative regulation of gene silencing (GO:0060969) | 3.33139191 |
| 57 | protein maturation by protein folding (GO:0022417) | 3.29135555 |
| 58 | mitotic metaphase plate congression (GO:0007080) | 3.27826858 |
| 59 | negative regulation of mRNA processing (GO:0050686) | 3.26849998 |
| 60 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.24856390 |
| 61 | activated T cell proliferation (GO:0050798) | 3.18615617 |
| 62 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.18462202 |
| 63 | negative regulation of cell killing (GO:0031342) | 3.18462202 |
| 64 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377) | 3.17564379 |
| 65 | mRNA splicing, via spliceosome (GO:0000398) | 3.17564379 |
| 66 | regulation of gene silencing (GO:0060968) | 3.17325014 |
| 67 | positive regulation of autophagy (GO:0010508) | 3.16438046 |
| 68 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.15802086 |
| 69 | cellular response to arsenic-containing substance (GO:0071243) | 3.15677017 |
| 70 | RNA splicing, via transesterification reactions (GO:0000375) | 3.14539760 |
| 71 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.13622416 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 3.13590657 |
| 73 | histone exchange (GO:0043486) | 3.12594313 |
| 74 | actin nucleation (GO:0045010) | 3.10838862 |
| 75 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.10695468 |
| 76 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.10695468 |
| 77 | negative regulation of mRNA metabolic process (GO:1903312) | 3.08191164 |
| 78 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.08162282 |
| 79 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.08162282 |
| 80 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.08162282 |
| 81 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.08162282 |
| 82 | negative regulation of sister chromatid segregation (GO:0033046) | 3.08162282 |
| 83 | termination of RNA polymerase II transcription (GO:0006369) | 3.06645809 |
| 84 | negative regulation of chromosome segregation (GO:0051985) | 3.06535515 |
| 85 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.05988647 |
| 86 | ribosome assembly (GO:0042255) | 3.05794120 |
| 87 | response to nerve growth factor (GO:1990089) | 3.03934426 |
| 88 | cellular response to nerve growth factor stimulus (GO:1990090) | 3.03934426 |
| 89 | DNA strand elongation (GO:0022616) | 3.03474437 |
| 90 | respiratory burst (GO:0045730) | 3.01691324 |
| 91 | mRNA splice site selection (GO:0006376) | 3.01492021 |
| 92 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.01428557 |
| 93 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.01428557 |
| 94 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.01428557 |
| 95 | negative regulation of interleukin-17 production (GO:0032700) | 3.01382316 |
| 96 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.00992019 |
| 97 | DNA topological change (GO:0006265) | 3.00354745 |
| 98 | nucleosome disassembly (GO:0006337) | 2.99907016 |
| 99 | protein-DNA complex disassembly (GO:0032986) | 2.99907016 |
| 100 | signal peptide processing (GO:0006465) | 2.97287164 |
| 101 | mRNA stabilization (GO:0048255) | 2.96807628 |
| 102 | RNA stabilization (GO:0043489) | 2.96807628 |
| 103 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.94356759 |
| 104 | regulation of mRNA stability (GO:0043488) | 2.91946607 |
| 105 | sequestering of actin monomers (GO:0042989) | 2.88680732 |
| 106 | DNA ligation (GO:0006266) | 2.87596385 |
| 107 | DNA replication checkpoint (GO:0000076) | 2.86255448 |
| 108 | serine family amino acid biosynthetic process (GO:0009070) | 2.86231984 |
| 109 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.83921244 |
| 110 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.83921244 |
| 111 | response to peptidoglycan (GO:0032494) | 2.83227986 |
| 112 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82889998 |
| 113 | regulation of chromosome segregation (GO:0051983) | 2.81996678 |
| 114 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.79091024 |
| 115 | spliceosomal snRNP assembly (GO:0000387) | 2.78954365 |
| 116 | chromatin assembly or disassembly (GO:0006333) | 2.78907294 |
| 117 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.78014793 |
| 118 | convergent extension (GO:0060026) | 2.76953773 |
| 119 | ribosomal small subunit assembly (GO:0000028) | 2.76860875 |
| 120 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.75487216 |
| 121 | nucleobase biosynthetic process (GO:0046112) | 2.75463438 |
| 122 | positive regulation of lamellipodium assembly (GO:0010592) | 2.74850033 |
| 123 | mitotic spindle checkpoint (GO:0071174) | 2.74172395 |
| 124 | regulation of chromatin silencing (GO:0031935) | 2.72901143 |
| 125 | lung-associated mesenchyme development (GO:0060484) | 2.71985140 |
| 126 | pore complex assembly (GO:0046931) | 2.71017133 |
| 127 | regulation of RNA stability (GO:0043487) | 2.70349181 |
| 128 | ribosomal large subunit biogenesis (GO:0042273) | 2.70338029 |
| 129 | low-density lipoprotein particle clearance (GO:0034383) | 2.69558039 |
| 130 | regulation of mitochondrial translation (GO:0070129) | 2.68694910 |
| 131 | mitotic spindle assembly checkpoint (GO:0007094) | 2.68521895 |
| 132 | spindle checkpoint (GO:0031577) | 2.68111415 |
| 133 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.66429903 |
| 134 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.66429903 |
| 135 | regulation of translational fidelity (GO:0006450) | 2.65386751 |
| 136 | nerve growth factor signaling pathway (GO:0038180) | 2.65315129 |
| 137 | positive regulation of leukocyte degranulation (GO:0043302) | 2.64856406 |
| 138 | chromatin assembly (GO:0031497) | 2.64680326 |
| 139 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.64495495 |
| 140 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.64495495 |
| 141 | positive regulation of chromosome segregation (GO:0051984) | 2.64089890 |
| 142 | spindle assembly checkpoint (GO:0071173) | 2.63458168 |
| 143 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.63104291 |
| 144 | glycosphingolipid catabolic process (GO:0046479) | 2.62882084 |
| 145 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.62147819 |
| 146 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.61723609 |
| 147 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.61722792 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.61707478 |
| 149 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.61025873 |
| 150 | positive regulation of nuclease activity (GO:0032075) | 2.56920183 |
| 151 | autophagic vacuole assembly (GO:0000045) | 2.56222423 |
| 152 | positive regulation of actin filament depolymerization (GO:0030836) | 2.54799964 |
| 153 | granulocyte activation (GO:0036230) | 2.54183573 |
| 154 | membrane budding (GO:0006900) | 2.53804360 |
| 155 | leukocyte aggregation (GO:0070486) | 2.52432941 |
| 156 | positive regulation of macroautophagy (GO:0016239) | 2.52142040 |
| 157 | Rap protein signal transduction (GO:0032486) | 2.51929088 |
| 158 | macrophage activation involved in immune response (GO:0002281) | 2.50662475 |
| 159 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.48716389 |
| 160 | sexual reproduction (GO:0019953) | 2.47356994 |
| 161 | eosinophil chemotaxis (GO:0048245) | 2.46424637 |
| 162 | regulation of nuclease activity (GO:0032069) | 2.45585250 |
| 163 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.45363970 |
| 164 | regulation of podosome assembly (GO:0071801) | 2.43095325 |
| 165 | myeloid cell homeostasis (GO:0002262) | 2.42268770 |
| 166 | neutrophil activation (GO:0042119) | 2.40251420 |
| 167 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.39454597 |
| 168 | intestinal epithelial cell development (GO:0060576) | 2.38330183 |
| 169 | negative regulation of inclusion body assembly (GO:0090084) | 2.37337220 |
| 170 | glycolipid catabolic process (GO:0019377) | 2.36309682 |
| 171 | regulation of translational termination (GO:0006449) | 2.35897914 |
| 172 | ER overload response (GO:0006983) | 2.35590923 |
| 173 | cellular response to unfolded protein (GO:0034620) | 2.35390280 |
| 174 | cortical actin cytoskeleton organization (GO:0030866) | 2.35243488 |
| 175 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.34451550 |
| 176 | sequestering of metal ion (GO:0051238) | 2.33596640 |
| 177 | Fc receptor mediated stimulatory signaling pathway (GO:0002431) | 2.33127928 |
| 178 | positive regulation of mast cell activation (GO:0033005) | 2.31712007 |
| 179 | neurofilament cytoskeleton organization (GO:0060052) | 2.29248322 |
| 180 | phagosome maturation (GO:0090382) | 2.28234795 |
| 181 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.28055458 |
| 182 | regulation of interleukin-17 production (GO:0032660) | 2.27216039 |
| 183 | Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096) | 2.26815068 |
| 184 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002 | 2.26815068 |
| 185 | Fc-gamma receptor signaling pathway (GO:0038094) | 2.26815068 |
| 186 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.26363010 |
| 187 | magnesium ion transport (GO:0015693) | 2.26285797 |
| 188 | regulation of defense response to virus by virus (GO:0050690) | 2.25500604 |
| 189 | ER-nucleus signaling pathway (GO:0006984) | 2.25267187 |
| 190 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.24597441 |
| 191 | response to host immune response (GO:0052572) | 2.23032175 |
| 192 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.23032175 |
| 193 | interferon-gamma secretion (GO:0072643) | 2.22883085 |
| 194 | sphingolipid catabolic process (GO:0030149) | 2.22373061 |
| 195 | cellular response to topologically incorrect protein (GO:0035967) | 2.22370801 |
| 196 | ceramide catabolic process (GO:0046514) | 2.21543499 |
| 197 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.20722318 |
| 198 | regulation of histone phosphorylation (GO:0033127) | 2.20556352 |
| 199 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.19728235 |
| 200 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.19686004 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.96084237 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.86430253 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.32494069 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.89102296 |
| 5 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.71144622 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.03554004 |
| 7 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.01480607 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.00895103 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.98761015 |
| 10 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.92694632 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89762028 |
| 12 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.85853412 |
| 13 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.85853412 |
| 14 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.85853412 |
| 15 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.84874683 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.84666872 |
| 17 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.75657246 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74611839 |
| 19 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.74148668 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.74091790 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.69664445 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.64434864 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63003965 |
| 24 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.54525965 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47526700 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42292556 |
| 27 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.40653195 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.38794753 |
| 29 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.37394246 |
| 30 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.37185758 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.31529967 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.28713733 |
| 33 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.28681319 |
| 34 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.26658520 |
| 35 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.23314578 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 2.20405532 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 2.16848463 |
| 38 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.14635548 |
| 39 | TTF2_22483619_ChIP-Seq_HELA_Human | 2.12424785 |
| 40 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.11847633 |
| 41 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.10575058 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.08602354 |
| 43 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.07454693 |
| 44 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.05627559 |
| 45 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01308787 |
| 46 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 2.01051866 |
| 47 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.00807065 |
| 48 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.00524411 |
| 49 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.93533088 |
| 50 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.93196173 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.93075524 |
| 52 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.92316043 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.92188175 |
| 54 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.91788359 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.91157447 |
| 56 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.87175781 |
| 57 | MYC_22102868_ChIP-Seq_BL_Human | 1.84972390 |
| 58 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.80023476 |
| 59 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.79575556 |
| 60 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.79290613 |
| 61 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.77779056 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.77168485 |
| 63 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76480473 |
| 64 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.75711939 |
| 65 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.75504244 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.75023151 |
| 67 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.72903589 |
| 68 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71949484 |
| 69 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.70358948 |
| 70 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.69584825 |
| 71 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.68384383 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.67723956 |
| 73 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.67229905 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.66123571 |
| 75 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65809417 |
| 76 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65479889 |
| 77 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.64750924 |
| 78 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.64647904 |
| 79 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.63739673 |
| 80 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.62879597 |
| 81 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.61048977 |
| 82 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.59226534 |
| 83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.58487785 |
| 84 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58451034 |
| 85 | ATF3_27146783_Chip-Seq_COLON_Human | 1.57579172 |
| 86 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57219905 |
| 87 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.56808606 |
| 88 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.56723756 |
| 89 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.56704862 |
| 90 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.55292460 |
| 91 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54125314 |
| 92 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.53806170 |
| 93 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.53235248 |
| 94 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52327782 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.51737064 |
| 96 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.51315387 |
| 97 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.51243937 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50656232 |
| 99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.48789713 |
| 100 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.47189138 |
| 101 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44230719 |
| 102 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.42684138 |
| 103 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.42320431 |
| 104 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42063550 |
| 105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41668440 |
| 106 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.40740775 |
| 107 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.38456079 |
| 108 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.38271664 |
| 109 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.37490888 |
| 110 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37117855 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.36549486 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36197293 |
| 113 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.35278068 |
| 114 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.34477970 |
| 115 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.34466689 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.34402520 |
| 117 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.33548708 |
| 118 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33478090 |
| 119 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.30922390 |
| 120 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.28746794 |
| 121 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.28377879 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27634794 |
| 123 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.26771112 |
| 124 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26228214 |
| 125 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.26020562 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25892313 |
| 127 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.25790696 |
| 128 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.25570039 |
| 129 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.25235685 |
| 130 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24573155 |
| 131 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.24453302 |
| 132 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.23616783 |
| 133 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.23211861 |
| 134 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.23117365 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22697756 |
| 136 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22530150 |
| 137 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.21872646 |
| 138 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21827581 |
| 139 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.21453601 |
| 140 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.21419533 |
| 141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.21027503 |
| 142 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.20301183 |
| 143 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.19753021 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.18751745 |
| 145 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17023169 |
| 146 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16754349 |
| 147 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15683120 |
| 148 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.15498261 |
| 149 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.15433730 |
| 150 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.15202692 |
| 151 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.15151141 |
| 152 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.14878188 |
| 153 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.14853186 |
| 154 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.14156284 |
| 155 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.13891952 |
| 156 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.09302604 |
| 157 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08727474 |
| 158 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08674630 |
| 159 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.08622919 |
| 160 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.08265705 |
| 161 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.08084875 |
| 162 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07021554 |
| 163 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06944855 |
| 164 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.05892604 |
| 165 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.03074903 |
| 166 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02098557 |
| 167 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.01891966 |
| 168 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.01678807 |
| 169 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00233346 |
| 170 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98549802 |
| 171 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97952167 |
| 172 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97362572 |
| 173 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95962635 |
| 174 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94539347 |
| 175 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94238411 |
| 176 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.94108118 |
| 177 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94008985 |
| 178 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.93087855 |
| 179 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.92782335 |
| 180 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.92772174 |
| 181 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.92349548 |
| 182 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92144060 |
| 183 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92072440 |
| 184 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91708543 |
| 185 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.90960454 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.01460735 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.58173382 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.27611597 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.11832675 |
| 5 | MP0003436_decreased_susceptibility_to | 2.98538909 |
| 6 | MP0003890_abnormal_embryonic-extraembry | 2.97985959 |
| 7 | MP0002254_reproductive_system_inflammat | 2.95683231 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.71700630 |
| 9 | MP0008932_abnormal_embryonic_tissue | 2.67281382 |
| 10 | MP0006082_CNS_inflammation | 2.65216741 |
| 11 | MP0009840_abnormal_foam_cell | 2.64905091 |
| 12 | MP0003567_abnormal_fetal_cardiomyocyte | 2.63683471 |
| 13 | MP0009672_abnormal_birth_weight | 2.63155841 |
| 14 | MP0005000_abnormal_immune_tolerance | 2.59461367 |
| 15 | MP0003941_abnormal_skin_development | 2.58099769 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.54997245 |
| 17 | MP0001293_anophthalmia | 2.54488302 |
| 18 | MP0003172_abnormal_lysosome_physiology | 2.52791029 |
| 19 | MP0010094_abnormal_chromosome_stability | 2.51311497 |
| 20 | MP0003122_maternal_imprinting | 2.45561926 |
| 21 | MP0003077_abnormal_cell_cycle | 2.45180514 |
| 22 | MP0006292_abnormal_olfactory_placode | 2.44789660 |
| 23 | MP0010234_abnormal_vibrissa_follicle | 2.34122975 |
| 24 | MP0001529_abnormal_vocalization | 2.32826735 |
| 25 | MP0008058_abnormal_DNA_repair | 2.31111383 |
| 26 | MP0000604_amyloidosis | 2.30167093 |
| 27 | MP0001730_embryonic_growth_arrest | 2.28307283 |
| 28 | MP0008877_abnormal_DNA_methylation | 2.25936454 |
| 29 | MP0001835_abnormal_antigen_presentation | 2.23139001 |
| 30 | MP0003329_amyloid_beta_deposits | 2.17786142 |
| 31 | MP0003183_abnormal_peptide_metabolism | 2.11662734 |
| 32 | MP0002148_abnormal_hypersensitivity_rea | 2.10612305 |
| 33 | MP0004947_skin_inflammation | 2.04199618 |
| 34 | MP0002697_abnormal_eye_size | 2.02173418 |
| 35 | MP0000537_abnormal_urethra_morphology | 2.00630985 |
| 36 | MP0004510_myositis | 1.97923119 |
| 37 | MP0001188_hyperpigmentation | 1.96508539 |
| 38 | MP0002419_abnormal_innate_immunity | 1.94718029 |
| 39 | MP0003136_yellow_coat_color | 1.92228812 |
| 40 | MP0005387_immune_system_phenotype | 1.92108618 |
| 41 | MP0001790_abnormal_immune_system | 1.92108618 |
| 42 | MP0002723_abnormal_immune_serum | 1.90273475 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.89173637 |
| 44 | MP0003937_abnormal_limbs/digits/tail_de | 1.89140993 |
| 45 | MP0008260_abnormal_autophagy | 1.88902767 |
| 46 | MP0003119_abnormal_digestive_system | 1.87457507 |
| 47 | MP0002084_abnormal_developmental_patter | 1.86574198 |
| 48 | MP0000685_abnormal_immune_system | 1.84122783 |
| 49 | MP0002085_abnormal_embryonic_tissue | 1.83888239 |
| 50 | MP0005671_abnormal_response_to | 1.83302309 |
| 51 | MP0000350_abnormal_cell_proliferation | 1.83268121 |
| 52 | MP0001672_abnormal_embryogenesis/_devel | 1.78319436 |
| 53 | MP0005380_embryogenesis_phenotype | 1.78319436 |
| 54 | MP0001800_abnormal_humoral_immune | 1.78020321 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.77556854 |
| 56 | MP0003121_genomic_imprinting | 1.77104262 |
| 57 | MP0008057_abnormal_DNA_replication | 1.76687710 |
| 58 | MP0004133_heterotaxia | 1.73659038 |
| 59 | MP0001819_abnormal_immune_cell | 1.72715352 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.71288815 |
| 61 | MP0009785_altered_susceptibility_to | 1.70178685 |
| 62 | MP0002405_respiratory_system_inflammati | 1.69981766 |
| 63 | MP0001697_abnormal_embryo_size | 1.68775219 |
| 64 | MP0009333_abnormal_splenocyte_physiolog | 1.68632814 |
| 65 | MP0002693_abnormal_pancreas_physiology | 1.67624396 |
| 66 | MP0005025_abnormal_response_to | 1.62470637 |
| 67 | MP0001286_abnormal_eye_development | 1.61381920 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 1.60805721 |
| 69 | MP0000049_abnormal_middle_ear | 1.58799182 |
| 70 | MP0008007_abnormal_cellular_replicative | 1.57649653 |
| 71 | MP0005394_taste/olfaction_phenotype | 1.55989863 |
| 72 | MP0005499_abnormal_olfactory_system | 1.55989863 |
| 73 | MP0009703_decreased_birth_body | 1.55727615 |
| 74 | MP0003984_embryonic_growth_retardation | 1.55324462 |
| 75 | MP0000566_synostosis | 1.55109963 |
| 76 | MP0005310_abnormal_salivary_gland | 1.54950445 |
| 77 | MP0003221_abnormal_cardiomyocyte_apopto | 1.54277297 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.53352045 |
| 79 | MP0003861_abnormal_nervous_system | 1.51757198 |
| 80 | MP0002088_abnormal_embryonic_growth/wei | 1.51081407 |
| 81 | MP0002653_abnormal_ependyma_morphology | 1.47736275 |
| 82 | MP0003718_maternal_effect | 1.44263213 |
| 83 | MP0000778_abnormal_nervous_system | 1.43649680 |
| 84 | MP0003123_paternal_imprinting | 1.42650098 |
| 85 | MP0003448_altered_tumor_morphology | 1.41542402 |
| 86 | MP0002080_prenatal_lethality | 1.40792255 |
| 87 | MP0003693_abnormal_embryo_hatching | 1.40637589 |
| 88 | MP0010030_abnormal_orbit_morphology | 1.39855131 |
| 89 | MP0002092_abnormal_eye_morphology | 1.39583785 |
| 90 | MP0000920_abnormal_myelination | 1.37685256 |
| 91 | MP0001845_abnormal_inflammatory_respons | 1.37182400 |
| 92 | MP0001299_abnormal_eye_distance/ | 1.36812970 |
| 93 | MP0003091_abnormal_cell_migration | 1.35965661 |
| 94 | MP0000013_abnormal_adipose_tissue | 1.34659617 |
| 95 | MP0001984_abnormal_olfaction | 1.32533049 |
| 96 | MP0002909_abnormal_adrenal_gland | 1.32195608 |
| 97 | MP0006035_abnormal_mitochondrial_morpho | 1.31374654 |
| 98 | MP0003315_abnormal_perineum_morphology | 1.30886236 |
| 99 | MP0001851_eye_inflammation | 1.30628821 |
| 100 | MP0003191_abnormal_cellular_cholesterol | 1.29851495 |
| 101 | MP0000716_abnormal_immune_system | 1.29076910 |
| 102 | MP0002233_abnormal_nose_morphology | 1.28325015 |
| 103 | MP0005076_abnormal_cell_differentiation | 1.27950266 |
| 104 | MP0003634_abnormal_glial_cell | 1.27906550 |
| 105 | MP0003690_abnormal_glial_cell | 1.27056526 |
| 106 | MP0008789_abnormal_olfactory_epithelium | 1.26537189 |
| 107 | MP0003566_abnormal_cell_adhesion | 1.26179875 |
| 108 | MP0002638_abnormal_pupillary_reflex | 1.25303421 |
| 109 | MP0005645_abnormal_hypothalamus_physiol | 1.24401314 |
| 110 | MP0000858_altered_metastatic_potential | 1.23621998 |
| 111 | MP0002111_abnormal_tail_morphology | 1.21927242 |
| 112 | MP0002398_abnormal_bone_marrow | 1.21273564 |
| 113 | MP0003195_calcinosis | 1.17215375 |
| 114 | MP0001944_abnormal_pancreas_morphology | 1.16765180 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 1.14922502 |
| 116 | MP0000313_abnormal_cell_death | 1.13381425 |
| 117 | MP0004858_abnormal_nervous_system | 1.12985827 |
| 118 | MP0003938_abnormal_ear_development | 1.11757487 |
| 119 | MP0002102_abnormal_ear_morphology | 1.08653509 |
| 120 | MP0003724_increased_susceptibility_to | 1.07633350 |
| 121 | MP0000428_abnormal_craniofacial_morphol | 1.06747492 |
| 122 | MP0004742_abnormal_vestibular_system | 1.06714436 |
| 123 | MP0002086_abnormal_extraembryonic_tissu | 1.05592532 |
| 124 | MP0004270_analgesia | 1.05213424 |
| 125 | MP0009697_abnormal_copulation | 1.04959535 |
| 126 | MP0005464_abnormal_platelet_physiology | 1.04660713 |
| 127 | MP0010678_abnormal_skin_adnexa | 1.03542684 |
| 128 | MP0003787_abnormal_imprinting | 1.02567783 |
| 129 | MP0003763_abnormal_thymus_physiology | 1.01257511 |
| 130 | MP0003115_abnormal_respiratory_system | 0.98442101 |
| 131 | MP0004185_abnormal_adipocyte_glucose | 0.97235251 |
| 132 | MP0002933_joint_inflammation | 0.95016457 |
| 133 | MP0002429_abnormal_blood_cell | 0.94963946 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.93477671 |
| 135 | MP0002998_abnormal_bone_remodeling | 0.92781029 |
| 136 | MP0010155_abnormal_intestine_physiology | 0.92424961 |
| 137 | MP0001849_ear_inflammation | 0.92329322 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.92031590 |
| 139 | MP0002722_abnormal_immune_system | 0.91042208 |
| 140 | MP0001727_abnormal_embryo_implantation | 0.90564549 |
| 141 | MP0003755_abnormal_palate_morphology | 0.90270030 |
| 142 | MP0009278_abnormal_bone_marrow | 0.89656394 |
| 143 | MP0001915_intracranial_hemorrhage | 0.89027827 |
| 144 | MP0002081_perinatal_lethality | 0.88829704 |
| 145 | MP0010386_abnormal_urinary_bladder | 0.88314548 |
| 146 | MP0002938_white_spotting | 0.87945176 |
| 147 | MP0002152_abnormal_brain_morphology | 0.86392432 |
| 148 | MP0010307_abnormal_tumor_latency | 0.85541031 |
| 149 | MP0005391_vision/eye_phenotype | 0.84849686 |
| 150 | MP0002009_preneoplasia | 0.84125119 |
| 151 | MP0001542_abnormal_bone_strength | 0.84041162 |
| 152 | MP0008469_abnormal_protein_level | 0.83694415 |
| 153 | MP0003878_abnormal_ear_physiology | 0.83052250 |
| 154 | MP0005377_hearing/vestibular/ear_phenot | 0.83052250 |
| 155 | MP0004811_abnormal_neuron_physiology | 0.80853447 |
| 156 | MP0000432_abnormal_head_morphology | 0.80804913 |
| 157 | MP0003942_abnormal_urinary_system | 0.79833681 |
| 158 | MP0003866_abnormal_defecation | 0.79750020 |
| 159 | MP0000955_abnormal_spinal_cord | 0.79089829 |
| 160 | MP0001853_heart_inflammation | 0.78421434 |
| 161 | MP0005621_abnormal_cell_physiology | 0.77941121 |
| 162 | MP0002751_abnormal_autonomic_nervous | 0.76307251 |
| 163 | MP0003795_abnormal_bone_structure | 0.76249664 |
| 164 | MP0000358_abnormal_cell_content/ | 0.75501548 |
| 165 | MP0000343_altered_response_to | 0.75466415 |
| 166 | MP0003385_abnormal_body_wall | 0.74922152 |
| 167 | MP0002089_abnormal_postnatal_growth/wei | 0.74891886 |
| 168 | MP0003656_abnormal_erythrocyte_physiolo | 0.73924591 |
| 169 | MP0002210_abnormal_sex_determination | 0.73121084 |
| 170 | MP0009379_abnormal_foot_pigmentation | 0.72848422 |
| 171 | MP0000733_abnormal_muscle_development | 0.72832681 |
| 172 | MP0005379_endocrine/exocrine_gland_phen | 0.72815392 |
| 173 | MP0000747_muscle_weakness | 0.72370871 |
| 174 | MP0003935_abnormal_craniofacial_develop | 0.72258463 |
| 175 | MP0003075_altered_response_to | 0.72112743 |
| 176 | MP0002090_abnormal_vision | 0.72036589 |
| 177 | MP0000631_abnormal_neuroendocrine_gland | 0.71619202 |
| 178 | MP0006072_abnormal_retinal_apoptosis | 0.71443795 |
| 179 | MP0000003_abnormal_adipose_tissue | 0.70636092 |
| 180 | MP0000490_abnormal_crypts_of | 0.69219919 |
| 181 | MP0008961_abnormal_basal_metabolism | 0.69063069 |
| 182 | MP0001216_abnormal_epidermal_layer | 0.69041020 |
| 183 | MP0001145_abnormal_male_reproductive | 0.68778193 |
| 184 | MP0001340_abnormal_eyelid_morphology | 0.68718056 |
| 185 | MP0000703_abnormal_thymus_morphology | 0.68577965 |
| 186 | MP0002163_abnormal_gland_morphology | 0.67168800 |
| 187 | MP0001986_abnormal_taste_sensitivity | 0.66931234 |
| 188 | MP0005390_skeleton_phenotype | 0.66746949 |
| 189 | MP0003880_abnormal_central_pattern | 0.66497865 |
| 190 | MP0005397_hematopoietic_system_phenotyp | 0.66257808 |
| 191 | MP0009053_abnormal_anal_canal | 0.64662558 |
| 192 | MP0001177_atelectasis | 0.63610754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cortical dysplasia (HP:0002539) | 4.83000844 |
| 2 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.73068907 |
| 3 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.73068907 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.73068907 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 4.56032484 |
| 6 | Dysostosis multiplex (HP:0000943) | 4.37960134 |
| 7 | Hepatoblastoma (HP:0002884) | 4.32206280 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.07978861 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.96725724 |
| 10 | Diminished motivation (HP:0000745) | 3.90018353 |
| 11 | Spastic diplegia (HP:0001264) | 3.73037202 |
| 12 | Apathy (HP:0000741) | 3.62368082 |
| 13 | Abnormality of the labia minora (HP:0012880) | 3.62197074 |
| 14 | Recurrent abscess formation (HP:0002722) | 3.58603155 |
| 15 | Disinhibition (HP:0000734) | 3.56537334 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.55771088 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.54040207 |
| 18 | Septo-optic dysplasia (HP:0100842) | 3.52046807 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.43742952 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.43742952 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.43269739 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.37507366 |
| 23 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.37351229 |
| 24 | Abnormality of macrophages (HP:0004311) | 3.34217613 |
| 25 | Colon cancer (HP:0003003) | 3.28459562 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.06987338 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.06987338 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.06987338 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.88347663 |
| 30 | Neurofibrillary tangles (HP:0002185) | 2.83918303 |
| 31 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.82841134 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 2.81559402 |
| 33 | Choanal stenosis (HP:0000452) | 2.75080568 |
| 34 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72484163 |
| 35 | Obstructive lung disease (HP:0006536) | 2.72484163 |
| 36 | Abnormal lung lobation (HP:0002101) | 2.72278854 |
| 37 | Hyperglycinemia (HP:0002154) | 2.67912292 |
| 38 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.66442233 |
| 39 | Progressive neurologic deterioration (HP:0002344) | 2.66290667 |
| 40 | Restlessness (HP:0000711) | 2.66228750 |
| 41 | Bilateral microphthalmos (HP:0007633) | 2.65899144 |
| 42 | Multiple enchondromatosis (HP:0005701) | 2.65080284 |
| 43 | Thoracolumbar scoliosis (HP:0002944) | 2.58734212 |
| 44 | Embryonal renal neoplasm (HP:0011794) | 2.56173392 |
| 45 | Global brain atrophy (HP:0002283) | 2.55888398 |
| 46 | Nuclear cataract (HP:0100018) | 2.51724576 |
| 47 | Axonal loss (HP:0003447) | 2.51162750 |
| 48 | Medulloblastoma (HP:0002885) | 2.49016921 |
| 49 | Synostosis involving the elbow (HP:0003938) | 2.43305868 |
| 50 | Humeroradial synostosis (HP:0003041) | 2.43305868 |
| 51 | Personality changes (HP:0000751) | 2.40845602 |
| 52 | Maternal diabetes (HP:0009800) | 2.40065133 |
| 53 | Small epiphyses (HP:0010585) | 2.39656272 |
| 54 | Pelvic girdle muscle weakness (HP:0003749) | 2.38883079 |
| 55 | Abnormality of the septum pellucidum (HP:0007375) | 2.36709076 |
| 56 | Abnormal number of incisors (HP:0011064) | 2.36532778 |
| 57 | Reticulocytopenia (HP:0001896) | 2.33647226 |
| 58 | Hypercortisolism (HP:0001578) | 2.32653110 |
| 59 | Recurrent fungal infections (HP:0002841) | 2.32516915 |
| 60 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.32355782 |
| 61 | Peripheral hypomyelination (HP:0007182) | 2.31889843 |
| 62 | Chronic otitis media (HP:0000389) | 2.29870389 |
| 63 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.28959129 |
| 64 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.28959129 |
| 65 | Nasal polyposis (HP:0100582) | 2.27022737 |
| 66 | Cerebral inclusion bodies (HP:0100314) | 2.26853663 |
| 67 | Agitation (HP:0000713) | 2.26420045 |
| 68 | Hyperparathyroidism (HP:0000843) | 2.25799281 |
| 69 | Trigonocephaly (HP:0000243) | 2.25181372 |
| 70 | Clumsiness (HP:0002312) | 2.24925836 |
| 71 | Split foot (HP:0001839) | 2.23831472 |
| 72 | Mutism (HP:0002300) | 2.23786087 |
| 73 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.23284322 |
| 74 | Loss of speech (HP:0002371) | 2.21207537 |
| 75 | Hand muscle atrophy (HP:0009130) | 2.20704071 |
| 76 | Selective tooth agenesis (HP:0001592) | 2.20091967 |
| 77 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.19608848 |
| 78 | Myelomeningocele (HP:0002475) | 2.19302152 |
| 79 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.18948907 |
| 80 | Gastrointestinal carcinoma (HP:0002672) | 2.18948907 |
| 81 | Mediastinal lymphadenopathy (HP:0100721) | 2.18591703 |
| 82 | Hemivertebrae (HP:0002937) | 2.17921471 |
| 83 | Cellulitis (HP:0100658) | 2.17066285 |
| 84 | Esophageal atresia (HP:0002032) | 2.16629779 |
| 85 | Dysautonomia (HP:0002459) | 2.16481966 |
| 86 | Hypoglycemic seizures (HP:0002173) | 2.15805049 |
| 87 | Abnormality of homocysteine metabolism (HP:0010919) | 2.14696784 |
| 88 | Homocystinuria (HP:0002156) | 2.14696784 |
| 89 | J-shaped sella turcica (HP:0002680) | 2.14309685 |
| 90 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.14191001 |
| 91 | Horseshoe kidney (HP:0000085) | 2.14084828 |
| 92 | Poor head control (HP:0002421) | 2.14053642 |
| 93 | Recurrent viral infections (HP:0004429) | 2.13957505 |
| 94 | Absent septum pellucidum (HP:0001331) | 2.13704587 |
| 95 | Peripheral demyelination (HP:0011096) | 2.12730971 |
| 96 | Stenosis of the external auditory canal (HP:0000402) | 2.12226025 |
| 97 | Generalized hypotonia (HP:0001290) | 2.10635749 |
| 98 | Microvesicular hepatic steatosis (HP:0001414) | 2.10227839 |
| 99 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08281672 |
| 100 | Stomatitis (HP:0010280) | 2.07624603 |
| 101 | High anterior hairline (HP:0009890) | 2.07568649 |
| 102 | Absent eyebrow (HP:0002223) | 2.06920899 |
| 103 | Absent forearm bone (HP:0003953) | 2.05677484 |
| 104 | Aplasia involving forearm bones (HP:0009822) | 2.05677484 |
| 105 | Partial duplication of thumb phalanx (HP:0009944) | 2.05640062 |
| 106 | Carpal bone hypoplasia (HP:0001498) | 2.03701363 |
| 107 | Distal upper limb amyotrophy (HP:0007149) | 2.02850236 |
| 108 | Upper limb amyotrophy (HP:0009129) | 2.02850236 |
| 109 | Vertebral compression fractures (HP:0002953) | 2.02837757 |
| 110 | Vaginal fistula (HP:0004320) | 2.01051816 |
| 111 | Macrocytic anemia (HP:0001972) | 2.00614536 |
| 112 | Recurrent skin infections (HP:0001581) | 2.00411853 |
| 113 | Facial cleft (HP:0002006) | 2.00199806 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 2.00011326 |
| 115 | Abnormal hair whorl (HP:0010721) | 1.99233773 |
| 116 | Vasculitis (HP:0002633) | 1.98298993 |
| 117 | Chronic sinusitis (HP:0011109) | 1.97342808 |
| 118 | Meckel diverticulum (HP:0002245) | 1.94825813 |
| 119 | Akinesia (HP:0002304) | 1.94478893 |
| 120 | Shoulder girdle muscle weakness (HP:0003547) | 1.94322766 |
| 121 | Birth length less than 3rd percentile (HP:0003561) | 1.93330622 |
| 122 | Hypoplastic pelvis (HP:0008839) | 1.93255855 |
| 123 | Broad alveolar ridges (HP:0000187) | 1.92929720 |
| 124 | Increased nuchal translucency (HP:0010880) | 1.92889588 |
| 125 | Anophthalmia (HP:0000528) | 1.90939068 |
| 126 | Chronic bronchitis (HP:0004469) | 1.90822406 |
| 127 | Broad thumb (HP:0011304) | 1.90798570 |
| 128 | Absent radius (HP:0003974) | 1.89732280 |
| 129 | Ulnar claw (HP:0001178) | 1.89446943 |
| 130 | Bronchitis (HP:0012387) | 1.89128498 |
| 131 | Recurrent bronchitis (HP:0002837) | 1.87999226 |
| 132 | Rectal fistula (HP:0100590) | 1.87960355 |
| 133 | Rectovaginal fistula (HP:0000143) | 1.87960355 |
| 134 | Breast aplasia (HP:0100783) | 1.87593657 |
| 135 | Eosinophilia (HP:0001880) | 1.86991717 |
| 136 | Hypogonadotrophic hypogonadism (HP:0000044) | 1.86005821 |
| 137 | Broad foot (HP:0001769) | 1.85953310 |
| 138 | Uterine leiomyosarcoma (HP:0002891) | 1.85225586 |
| 139 | Leiomyosarcoma (HP:0100243) | 1.85225586 |
| 140 | Progressive external ophthalmoplegia (HP:0000590) | 1.82488051 |
| 141 | Gastrointestinal stroma tumor (HP:0100723) | 1.81473448 |
| 142 | Uterine neoplasm (HP:0010784) | 1.80311029 |
| 143 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80043503 |
| 144 | Abdominal situs inversus (HP:0003363) | 1.79132364 |
| 145 | Abnormality of abdominal situs (HP:0011620) | 1.79132364 |
| 146 | Hepatosplenomegaly (HP:0001433) | 1.78943961 |
| 147 | Increased IgE level (HP:0003212) | 1.78636384 |
| 148 | Bifid tongue (HP:0010297) | 1.78030531 |
| 149 | Neoplasm of the colon (HP:0100273) | 1.77808379 |
| 150 | Cellular immunodeficiency (HP:0005374) | 1.77608494 |
| 151 | Myopathic facies (HP:0002058) | 1.76941703 |
| 152 | Skull defect (HP:0001362) | 1.76490954 |
| 153 | Irregular vertebral endplates (HP:0003301) | 1.76376131 |
| 154 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.75899165 |
| 155 | Duplication of thumb phalanx (HP:0009942) | 1.75889204 |
| 156 | Scrotal hypoplasia (HP:0000046) | 1.75638802 |
| 157 | Hypergammaglobulinemia (HP:0010702) | 1.75572523 |
| 158 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.75257423 |
| 159 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74501262 |
| 160 | Restrictive lung disease (HP:0002091) | 1.74341770 |
| 161 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.74036889 |
| 162 | Abnormality of the ileum (HP:0001549) | 1.73901115 |
| 163 | Gastrointestinal atresia (HP:0002589) | 1.73645375 |
| 164 | Omphalocele (HP:0001539) | 1.73382953 |
| 165 | Episodic fever (HP:0001954) | 1.73146744 |
| 166 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.72958789 |
| 167 | Flattened epiphyses (HP:0003071) | 1.72931217 |
| 168 | Pustule (HP:0200039) | 1.72746351 |
| 169 | Biliary tract neoplasm (HP:0100574) | 1.72611542 |
| 170 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72474192 |
| 171 | Osteolytic defects of the hand bones (HP:0009699) | 1.72474192 |
| 172 | Neuroblastic tumors (HP:0004376) | 1.72399755 |
| 173 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.72399755 |
| 174 | Neuroblastoma (HP:0003006) | 1.72399755 |
| 175 | Primitive neuroectodermal tumor (HP:0030065) | 1.72399755 |
| 176 | Basal ganglia calcification (HP:0002135) | 1.71550631 |
| 177 | Agnosia (HP:0010524) | 1.71172592 |
| 178 | Rapidly progressive (HP:0003678) | 1.70869227 |
| 179 | Tetraparesis (HP:0002273) | 1.70436254 |
| 180 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.70391803 |
| 181 | Impulsivity (HP:0100710) | 1.70217216 |
| 182 | Embryonal neoplasm (HP:0002898) | 1.70179902 |
| 183 | Inappropriate behavior (HP:0000719) | 1.70085219 |
| 184 | Myositis (HP:0100614) | 1.69591754 |
| 185 | Postnatal microcephaly (HP:0005484) | 1.69355074 |
| 186 | Intestinal atresia (HP:0011100) | 1.67803229 |
| 187 | Increased CSF protein (HP:0002922) | 1.67468696 |
| 188 | Progressive muscle weakness (HP:0003323) | 1.65824077 |
| 189 | Partial agenesis of the corpus callosum (HP:0001338) | 1.65074134 |
| 190 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.65054760 |
| 191 | Onion bulb formation (HP:0003383) | 1.60134158 |
| 192 | Papilloma (HP:0012740) | 1.59468547 |
| 193 | Verrucae (HP:0200043) | 1.59468547 |
| 194 | Neurodegeneration (HP:0002180) | 1.58855896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SRPK1 | 3.89528314 |
| 2 | CDC7 | 3.70941049 |
| 3 | SCYL2 | 2.91420881 |
| 4 | ARAF | 2.77689143 |
| 5 | TTK | 2.75036616 |
| 6 | KSR2 | 2.67434225 |
| 7 | RIPK4 | 2.66588622 |
| 8 | MKNK1 | 2.66053870 |
| 9 | TSSK6 | 2.57236043 |
| 10 | TESK1 | 2.53586380 |
| 11 | MAP3K9 | 2.51897617 |
| 12 | LIMK1 | 2.48950039 |
| 13 | EPHB1 | 2.33717244 |
| 14 | CDK12 | 2.22437413 |
| 15 | ERBB3 | 2.21715921 |
| 16 | MKNK2 | 2.12546984 |
| 17 | TESK2 | 2.08757707 |
| 18 | DYRK3 | 2.04890900 |
| 19 | BRD4 | 1.96535203 |
| 20 | TRIB3 | 1.95596827 |
| 21 | MAP3K2 | 1.79475436 |
| 22 | STK24 | 1.76466354 |
| 23 | PLK3 | 1.74565962 |
| 24 | BLK | 1.72781277 |
| 25 | TBK1 | 1.69097381 |
| 26 | TNIK | 1.64042157 |
| 27 | LATS2 | 1.61735696 |
| 28 | PIM2 | 1.58770168 |
| 29 | MAPK15 | 1.56523590 |
| 30 | ERN1 | 1.55474888 |
| 31 | TYK2 | 1.54511542 |
| 32 | MAP3K11 | 1.51591442 |
| 33 | TAF1 | 1.49765550 |
| 34 | EPHA2 | 1.48686072 |
| 35 | MAP4K1 | 1.47701094 |
| 36 | RPS6KA4 | 1.47386806 |
| 37 | NTRK1 | 1.46056674 |
| 38 | MAP3K13 | 1.44337774 |
| 39 | BUB1 | 1.40819650 |
| 40 | MAP3K4 | 1.39482883 |
| 41 | MARK3 | 1.38437136 |
| 42 | TRIM28 | 1.36791504 |
| 43 | CSNK1G1 | 1.35232083 |
| 44 | PAK6 | 1.30040120 |
| 45 | MAP2K7 | 1.29646854 |
| 46 | MOS | 1.29243465 |
| 47 | PAK3 | 1.28470879 |
| 48 | KSR1 | 1.28408879 |
| 49 | STK38L | 1.27999375 |
| 50 | IRAK1 | 1.22393632 |
| 51 | PLK1 | 1.21327742 |
| 52 | WEE1 | 1.21117474 |
| 53 | TYRO3 | 1.20531839 |
| 54 | JAK3 | 1.19535849 |
| 55 | VRK2 | 1.18370119 |
| 56 | MAP3K1 | 1.18263411 |
| 57 | NEK1 | 1.18119206 |
| 58 | ZAP70 | 1.17280772 |
| 59 | CHEK2 | 1.15288426 |
| 60 | HIPK2 | 1.14845453 |
| 61 | MST4 | 1.14765415 |
| 62 | NME2 | 1.13082845 |
| 63 | LATS1 | 1.12896318 |
| 64 | LRRK2 | 1.12211412 |
| 65 | RAF1 | 1.10435838 |
| 66 | EIF2AK3 | 1.10347712 |
| 67 | PLK4 | 1.09344849 |
| 68 | PBK | 1.07519924 |
| 69 | CAMKK2 | 1.05284167 |
| 70 | MAP3K3 | 1.04410108 |
| 71 | FES | 1.03865790 |
| 72 | DYRK2 | 1.03587514 |
| 73 | MAPKAPK3 | 1.02660084 |
| 74 | FGFR4 | 0.99068139 |
| 75 | CSK | 0.97848850 |
| 76 | FGFR1 | 0.95544094 |
| 77 | ZAK | 0.95367537 |
| 78 | ITK | 0.95130985 |
| 79 | BRSK2 | 0.93396798 |
| 80 | CDK6 | 0.92744849 |
| 81 | MAP3K10 | 0.91286887 |
| 82 | SYK | 0.90270025 |
| 83 | IRAK4 | 0.89541457 |
| 84 | NEK2 | 0.89145058 |
| 85 | STK16 | 0.89122555 |
| 86 | HCK | 0.88270740 |
| 87 | ATR | 0.87262055 |
| 88 | EPHA3 | 0.86794659 |
| 89 | WNK3 | 0.86480213 |
| 90 | CSNK1A1L | 0.86047051 |
| 91 | DYRK1B | 0.85505502 |
| 92 | CDK4 | 0.85286335 |
| 93 | CHEK1 | 0.82805611 |
| 94 | UHMK1 | 0.82319159 |
| 95 | ALK | 0.81807164 |
| 96 | CSNK1G3 | 0.81233408 |
| 97 | MAP2K2 | 0.80639312 |
| 98 | SMG1 | 0.79608613 |
| 99 | MAP3K5 | 0.78264431 |
| 100 | PAK4 | 0.76664660 |
| 101 | LMTK2 | 0.76278805 |
| 102 | CDK11A | 0.76030427 |
| 103 | CDK7 | 0.75952476 |
| 104 | PNCK | 0.75164807 |
| 105 | MAP2K1 | 0.75095964 |
| 106 | CSNK1E | 0.74450094 |
| 107 | ATM | 0.73970046 |
| 108 | PKN2 | 0.73689929 |
| 109 | DYRK1A | 0.71701214 |
| 110 | CDK18 | 0.71557351 |
| 111 | STK10 | 0.71493873 |
| 112 | CDK14 | 0.70273833 |
| 113 | CDK15 | 0.70019993 |
| 114 | JAK1 | 0.69657692 |
| 115 | IRAK2 | 0.69025017 |
| 116 | EGFR | 0.68777875 |
| 117 | BMX | 0.68308984 |
| 118 | YES1 | 0.68257054 |
| 119 | CSNK1G2 | 0.67489709 |
| 120 | ACVR1B | 0.67214317 |
| 121 | JAK2 | 0.67005072 |
| 122 | NLK | 0.66232166 |
| 123 | GRK6 | 0.65471042 |
| 124 | FGR | 0.65396592 |
| 125 | ERBB4 | 0.65112313 |
| 126 | CDK2 | 0.64955913 |
| 127 | PTK2 | 0.64894594 |
| 128 | MAP3K8 | 0.64725390 |
| 129 | CLK1 | 0.63437814 |
| 130 | VRK1 | 0.63061440 |
| 131 | AURKB | 0.62150282 |
| 132 | AURKA | 0.61676993 |
| 133 | PDPK1 | 0.61353347 |
| 134 | MINK1 | 0.58642069 |
| 135 | PIM1 | 0.58024887 |
| 136 | CDK1 | 0.57968784 |
| 137 | DMPK | 0.57487145 |
| 138 | PASK | 0.57398071 |
| 139 | STK4 | 0.57328857 |
| 140 | NEK9 | 0.57272849 |
| 141 | BCR | 0.56241639 |
| 142 | EIF2AK1 | 0.55764631 |
| 143 | PAK1 | 0.55474350 |
| 144 | CAMK1G | 0.55335758 |
| 145 | TAOK1 | 0.53831112 |
| 146 | MAP3K14 | 0.53712004 |
| 147 | CDK19 | 0.52248987 |
| 148 | LCK | 0.52165862 |
| 149 | BRSK1 | 0.51862606 |
| 150 | ABL2 | 0.50624495 |
| 151 | PIK3CG | 0.50434094 |
| 152 | RPS6KA5 | 0.49795832 |
| 153 | PDK1 | 0.49425578 |
| 154 | CAMK1D | 0.48816364 |
| 155 | MAPKAPK2 | 0.48680953 |
| 156 | MAP3K12 | 0.48520153 |
| 157 | NME1 | 0.48467484 |
| 158 | STK3 | 0.47999482 |
| 159 | BRAF | 0.47713137 |
| 160 | EEF2K | 0.45545663 |
| 161 | CSNK2A2 | 0.45245559 |
| 162 | CSNK2A1 | 0.44456769 |
| 163 | IKBKB | 0.43652229 |
| 164 | STK39 | 0.43183382 |
| 165 | PRKDC | 0.43038804 |
| 166 | RPS6KA1 | 0.42953864 |
| 167 | MATK | 0.40151522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spliceosome_Homo sapiens_hsa03040 | 3.76494538 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.39726770 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.09618476 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.87481073 |
| 5 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.86843842 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.79597876 |
| 7 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 2.77610653 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.61970299 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.49684525 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.38409033 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.37975186 |
| 12 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.32968471 |
| 13 | Cell cycle_Homo sapiens_hsa04110 | 2.32661664 |
| 14 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.24198686 |
| 15 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.21440217 |
| 16 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.98842634 |
| 17 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.98624299 |
| 18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.97607533 |
| 19 | Basal transcription factors_Homo sapiens_hsa03022 | 1.97304169 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.92184713 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89839553 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.87819274 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.82671863 |
| 24 | RNA degradation_Homo sapiens_hsa03018 | 1.79762345 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.77083239 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.76745859 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75520546 |
| 28 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71397770 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.69463640 |
| 30 | Phagosome_Homo sapiens_hsa04145 | 1.68067208 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66042512 |
| 32 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.63739735 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.62018750 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.57329639 |
| 35 | Legionellosis_Homo sapiens_hsa05134 | 1.53689155 |
| 36 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49758631 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.49315856 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 1.48188022 |
| 39 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.47372701 |
| 40 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44710067 |
| 41 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.40597860 |
| 42 | Endocytosis_Homo sapiens_hsa04144 | 1.39568426 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.38977842 |
| 44 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.38385582 |
| 45 | Thyroid cancer_Homo sapiens_hsa05216 | 1.38197831 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.37254819 |
| 47 | Protein export_Homo sapiens_hsa03060 | 1.37193469 |
| 48 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.37007495 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.36735332 |
| 50 | Salmonella infection_Homo sapiens_hsa05132 | 1.36636937 |
| 51 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.36509764 |
| 52 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.34612676 |
| 53 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.31766456 |
| 54 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.30570580 |
| 55 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.28927051 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.28045738 |
| 57 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.27605478 |
| 58 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.27056714 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 1.26891418 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.24212444 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.23853930 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23558078 |
| 63 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.21695188 |
| 64 | Parkinsons disease_Homo sapiens_hsa05012 | 1.19288868 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 1.18876010 |
| 66 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.18809279 |
| 67 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18352525 |
| 68 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17206061 |
| 69 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.16970106 |
| 70 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.16497850 |
| 71 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.14730027 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 1.13880739 |
| 73 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.13420340 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13196882 |
| 75 | Proteasome_Homo sapiens_hsa03050 | 1.12706753 |
| 76 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12524985 |
| 77 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.08968006 |
| 78 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.08341836 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07889868 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 1.07525298 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07136267 |
| 82 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.04732508 |
| 83 | Homologous recombination_Homo sapiens_hsa03440 | 1.04482480 |
| 84 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03815661 |
| 85 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.03353026 |
| 86 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02624716 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02049472 |
| 88 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01536939 |
| 89 | Hepatitis B_Homo sapiens_hsa05161 | 1.01530126 |
| 90 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01131539 |
| 91 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.00320902 |
| 92 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97296721 |
| 93 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.96777513 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.96366149 |
| 95 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.96246626 |
| 96 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95625667 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.95563744 |
| 98 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95147350 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.94071446 |
| 100 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.93527140 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.93374064 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90848292 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.88773854 |
| 104 | Measles_Homo sapiens_hsa05162 | 0.87670016 |
| 105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83777757 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82580317 |
| 107 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.82432056 |
| 108 | Purine metabolism_Homo sapiens_hsa00230 | 0.81735977 |
| 109 | Tight junction_Homo sapiens_hsa04530 | 0.80786218 |
| 110 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.79551881 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.78396340 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.77788933 |
| 113 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77406615 |
| 114 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.76532370 |
| 115 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.76212362 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75729839 |
| 117 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75457207 |
| 118 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.74946400 |
| 119 | Malaria_Homo sapiens_hsa05144 | 0.74734227 |
| 120 | Axon guidance_Homo sapiens_hsa04360 | 0.74375384 |
| 121 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.74174710 |
| 122 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73326043 |
| 123 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72192748 |
| 124 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71561637 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71373883 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70595277 |
| 127 | Allograft rejection_Homo sapiens_hsa05330 | 0.70462938 |
| 128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70348453 |
| 129 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.70236134 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.69747851 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.69390972 |
| 132 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.68892482 |
| 133 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67142950 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67074640 |
| 135 | Influenza A_Homo sapiens_hsa05164 | 0.67006949 |
| 136 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.66179688 |
| 137 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.66104838 |
| 138 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.65860968 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.63839588 |
| 140 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63776974 |
| 141 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62910630 |
| 142 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.58704036 |
| 143 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.58378330 |
| 144 | Hepatitis C_Homo sapiens_hsa05160 | 0.57379150 |
| 145 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57107823 |
| 146 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55389980 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54077704 |
| 148 | Platelet activation_Homo sapiens_hsa04611 | 0.53805039 |
| 149 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.53472949 |
| 150 | Prostate cancer_Homo sapiens_hsa05215 | 0.52730214 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.52693423 |
| 152 | Sulfur relay system_Homo sapiens_hsa04122 | 0.51294143 |
| 153 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.49792784 |
| 154 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49386466 |
| 155 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48899798 |
| 156 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.48442411 |
| 157 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47540211 |
| 158 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47302025 |
| 159 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46794397 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | 0.43521984 |
| 161 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38957811 |
| 162 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.38633095 |
| 163 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.35622951 |
| 164 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34168957 |
| 165 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29859588 |
| 166 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29335881 |
| 167 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28025529 |
| 168 | Alcoholism_Homo sapiens_hsa05034 | 0.26952527 |
| 169 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.26800550 |
| 170 | Melanogenesis_Homo sapiens_hsa04916 | 0.26728718 |
| 171 | Gap junction_Homo sapiens_hsa04540 | 0.25938321 |
| 172 | Nicotine addiction_Homo sapiens_hsa05033 | 0.24710733 |
| 173 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23582221 |
| 174 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19997709 |
| 175 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.19250335 |
| 176 | HTLV-I infection_Homo sapiens_hsa05166 | 0.18942645 |
| 177 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.18767820 |
| 178 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.17578837 |
| 179 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.17208530 |
| 180 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16740456 |

